New pneumococcal vaccine approach successful in early tests

02/16/11 ( Children's Hospital Boston ) Researchers at Children's Hospital Boston and Genocea Biosciences, Inc., in collaboration with the international nonprofit organization PATH, developed a new vaccine candidate that is potentially cheaper and able to protect against any pneumococcal strain.

+

-

 

Press Release

03/17/11 Genocea Biosciences Inc. Posted on:17 Mar 11 Genocea Biosciences, Inc., a vaccine discovery and development company, announced today that Jessica Baker Flechtner, Vice President of Research, will be presenting at the 5th Biennial Meeting of the Chlamydia Basic Research Society on Monday, March 21st, 2011 at the Crowne Plaza Redondo Beach & Marina Hotel in Redondo Beach, CA. Additional work will ...

+

-

 

Genocea Biosciences, Inc to Present at the 5th Biennial Meeting of the Chlamydia Basic Research Society

03/17/11 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc., a vaccine discovery and development company, announced today that Jessica Baker Flechtner, Vice President of Research, will be presenting at the 5th Biennial Meeting of the Chlamydia Basic Research Society on Monday, March 21st, 2011 at the Crowne Plaza Redondo Beach & Marina Hotel in Redondo Beach, CA. Additional work will be ...

+

-